TP53 and Alzheimer disease: Pathway enrichment analyses revealed that high PCDS correlates with disease progression, characterized by significant enrichment of hypoxia, apoptosis, inflammatory response, p53 signaling, TNFα signaling, interferon response, and other pathways previously implicated in AD pathogenesis (53–56).